table of content
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Overall Market Size
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size: 2022 VS 2032
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Markets, 2022 & 2032
4.1.2 Allogeneic CAR T-Cells
4.1.3 Autologous CAR T-Cells
4.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2024-2032
4.2.3 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Others
5.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2024-2032
5.2.3 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2022 & 2032
6.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2024-2032
6.2.3 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.3.2 US Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.4.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.3 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.4 U.K. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.5 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.7 Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.8 Benelux Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.5 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.6 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.6.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.6.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.7.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7.4 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7.5 UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
7 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.1.4 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.2.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.3.4 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Legend Biotech
7.4.1 Legend Biotech Company Summary
7.4.2 Legend Biotech Business Overview
7.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.4.4 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Legend Biotech Key News & Latest Developments
7.5 Sorrento Therapeutics
7.5.1 Sorrento Therapeutics Company Summary
7.5.2 Sorrento Therapeutics Business Overview
7.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.5.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Sorrento Therapeutics Key News & Latest Developments
7.6 CARSGEN Therapeutics?Ltd
7.6.1 CARSGEN Therapeutics?Ltd Company Summary
7.6.2 CARSGEN Therapeutics?Ltd Business Overview
7.6.3 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.6.4 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 CARSGEN Therapeutics?Ltd Key News & Latest Developments
7.7 Juno Therapeutics
7.7.1 Juno Therapeutics Company Summary
7.7.2 Juno Therapeutics Business Overview
7.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.7.4 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Juno Therapeutics Key News & Latest Developments
7.8 Kite Pharma
7.8.1 Kite Pharma Company Summary
7.8.2 Kite Pharma Business Overview
7.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.8.4 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.8.5 Kite Pharma Key News & Latest Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Company Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.9.4 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.9.5 Atara Biotherapeutics Key News & Latest Developments
7.10 Carina Biotech
7.10.1 Carina Biotech Company Summary
7.10.2 Carina Biotech Business Overview
7.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.10.4 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.10.5 Carina Biotech Key News & Latest Developments
7.11 Guangzhou Xiangxue Pharmaceutical
7.11.1 Guangzhou Xiangxue Pharmaceutical Company Summary
7.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview
7.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.11.4 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.11.5 Guangzhou Xiangxue Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
